Brendan O'Grady
2019
In 2019, Brendan O'Grady earned a total compensation of $3.5M as Executive Vice President, North America Commercial at Teva Pharmaceutical Industries.
Compensation breakdown
| Bonus | $20,500 |
|---|---|
| Non-Equity Incentive Plan | $800,868 |
| Salary | $676,923 |
| Stock Awards | $1,899,988 |
| Other | $64,011 |
| Total | $3,462,290 |
O'Grady received $1.9M in stock awards, accounting for 55% of the total pay in 2019.
O'Grady also received $20.5K in bonus, $800.9K in non-equity incentive plan, $676.9K in salary and $64K in other compensation.
Rankings
In 2019, Brendan O'Grady's compensation ranked 3,523rd out of 13,971 executives tracked by ExecPay. In other words, O'Grady earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,523 out of 13,971 | 75th |
Division Manufacturing | 1,274 out of 5,701 | 78th |
Major group Chemicals And Allied Products | 439 out of 2,200 | 80th |
Industry group Drugs | 366 out of 1,886 | 81st |
Industry Pharmaceutical Preparations | 276 out of 1,398 | 80th |
Source: SEC filing on April 22, 2020.
O'Grady's colleagues
We found six more compensation records of executives who worked with Brendan O'Grady at Teva Pharmaceutical Industries in 2019.
2019
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2019
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2019
Carlo de Notaristefani
Teva Pharmaceutical Industries
Former Executive Vice President, Global Operations
2019
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
2019
Gianfranco Nazzi
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
2019
Eli Kalif
Teva Pharmaceutical Industries